Breast cancer is known to be a heterogeneous disease, and the different subtypes can be defined by the immunohistochemical (IHC) approach based on oestrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) and Ki-67 expression levels. Here, ERBB2 is linked to breast carcinoma.